XML 59 R46.htm IDEA: XBRL DOCUMENT v3.22.0.1
Parent Company Financial Statements (Tables)
12 Months Ended
Dec. 31, 2021
Condensed Financial Information Disclosure [Abstract]  
Schedule of Condensed Balance Sheets

Condensed Balance Sheets of the Company (Parent company only) for the periods presented are as follows:

(Dollars in thousands)

 

December 31,

 

ASSETS

 

2021

 

 

2020

 

Cash and cash equivalents

 

$

8,707

 

 

$

5,234

 

Investment in subsidiary

 

 

289,446

 

 

 

149,014

 

Other assets

 

 

1,856

 

 

 

1,498

 

Total assets

 

$

300,009

 

 

$

155,746

 

LIABILITIES AND SHAREHOLDERS' EQUITY

 

 

 

 

 

 

Other borrowings

 

$

1,000

 

 

$

33,875

 

Other liabilities

 

 

2

 

 

 

153

 

Total liabilities

 

 

1,002

 

 

 

34,028

 

Commitments and contingencies - ESOP-owned shares

 

 

 

 

 

1,302

 

Shareholders' equity:

 

 

 

 

 

 

Common stock

 

 

13,432

 

 

 

6,350

 

Additional paid-in capital

 

 

249,252

 

 

 

91,462

 

Retained earnings

 

 

36,029

 

 

 

24,605

 

Accumulated other comprehensive income

 

 

1,393

 

 

 

279

 

Treasury stock: at cost

 

 

(1,099

)

 

 

(978

)

 

 

 

299,007

 

 

 

121,718

 

Less: ESOP-owned shares

 

 

 

 

 

1,302

 

Total shareholders' equity

 

 

299,007

 

 

 

120,416

 

Total liabilities & shareholders' equity

 

$

300,009

 

 

$

155,746

 

Schedule of Condensed Statements of Income and Comprehensive Income

Condensed Statements of Income and Comprehensive Income of the Company (Parent company only) for the periods are as follows:

 

 

For the Years Ended December 31,

 

(Dollars in thousands)

 

2021

 

 

2020

 

 

2019

 

Interest expense:

 

 

 

 

 

 

 

 

 

Interest on notes payable

 

$

1,091

 

 

$

1,615

 

 

$

1,436

 

Total interest expense

 

 

1,091

 

 

 

1,615

 

 

 

1,436

 

Noninterest expense:

 

 

 

 

 

 

 

 

 

Legal and professional

 

 

680

 

 

 

1,233

 

 

 

937

 

Other

 

 

23

 

 

 

37

 

 

 

(1

)

Total noninterest expense

 

 

703

 

 

 

1,270

 

 

 

936

 

Loss before income tax expense and equity in undistributed earnings of subsidiaries

 

 

(1,794

)

 

 

(2,885

)

 

 

(2,372

)

Income tax benefit

 

 

359

 

 

 

384

 

 

 

498

 

Loss before equity in undistributed earnings of subsidiaries

 

 

(1,435

)

 

 

(2,501

)

 

 

(1,874

)

Equity in undistributed earnings of subsidiaries

 

 

12,859

 

 

 

14,616

 

 

 

4,255

 

Net income

 

$

11,424

 

 

$

12,115

 

 

$

2,381

 

Comprehensive income

 

$

12,538

 

 

$

12,394

 

 

$

2,404

 

 

Schedule of Condensed Statements of Cash Flows

Condensed Statements of Cash Flows of the Company (Parent company only) for the periods presented are as follows:

 

 

For the Years Ended December 31,

 

(Dollars in thousands)

 

2021

 

 

2020

 

 

2019

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

Net income

 

$

11,424

 

 

$

12,115

 

 

$

2,381

 

Adjustments to reconcile net income to net cash used in operating activities:

 

 

 

 

 

 

 

 

 

Equity in undistributed net income of subsidiaries

 

 

(12,859

)

 

 

(14,616

)

 

 

(4,255

)

Net change in other assets

 

 

(359

)

 

 

501

 

 

 

(1,485

)

Net change in other liabilities

 

 

(150

)

 

 

(320

)

 

 

393

 

Net cash used in operating activities

 

 

(1,944

)

 

 

(2,320

)

 

 

(2,966

)

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

Capital investment in subsidiaries

 

 

(125,800

)

 

 

 

 

 

(2,500

)

Net cash used in investing activities

 

 

(125,800

)

 

 

 

 

 

(2,500

)

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

Proceeds from other borrowings

 

 

 

 

 

11,000

 

 

 

8,000

 

Repayment of notes payable

 

 

(32,875

)

 

 

(7,500

)

 

 

(1,500

)

Proceeds from issuance of common stock

 

 

163,199

 

 

 

536

 

 

 

444

 

Proceeds from stock warrants exercised

 

 

19

 

 

 

 

 

 

 

Proceeds from stock options exercised

 

 

995

 

 

 

385

 

 

 

301

 

Net redemption of treasury stock

 

 

(121

)

 

 

(38

)

 

 

(527

)

Net cash provided by financing activities

 

 

131,217

 

 

 

4,383

 

 

 

6,718

 

Increase in cash and cash equivalents

 

 

3,473

 

 

 

2,063

 

 

 

1,252

 

Cash and cash equivalents at beginning of period

 

 

5,234

 

 

 

3,171

 

 

 

1,919

 

Cash and cash equivalents at end of period

 

$

8,707

 

 

$

5,234

 

 

$

3,171